Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Preoperative Staging of Lung Cancer with Combined PET–CT
580
Zitationen
25
Autoren
2009
Jahr
Abstract
The use of PET-CT for preoperative staging of NSCLC reduced both the total number of thoracotomies and the number of futile thoracotomies but did not affect overall mortality. (ClinicalTrials.gov number, NCT00867412.)
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.792 Zit.
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 · 11.470 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.861 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.979 Zit.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · 9.414 Zit.
Autoren
- Barbara Malene Fischer
- Ulrik Lassen
- Jann Mortensen
- S. S. Larsen
- Annika Loft
- A. K. Bertelsen
- Jesper Ravn
- Paul Frost Clementsen
- Asbjørn Høgholm
- Klaus Richter Larsen
- Torben Riis Rasmussen
- Susanne Keiding
- Asger Dirksen
- Oke Gerke
- Birgit Guldhammer Skov
- Ida Steffensen
- Hanne Helene Hansen
- Peter Vilmann
- Grete Krag Jacobsen
- Vibeke Backer
- Niels Maltbæk
- Jesper Holst Pedersen
- H. VERNON MADSEN
- Henrik Nielsen
- Liselotte Højgaard